[go: up one dir, main page]

SG11201706861QA - Compositions and methods for the treatment of "plaques and tangles" in humans and animals - Google Patents

Compositions and methods for the treatment of "plaques and tangles" in humans and animals

Info

Publication number
SG11201706861QA
SG11201706861QA SG11201706861QA SG11201706861QA SG11201706861QA SG 11201706861Q A SG11201706861Q A SG 11201706861QA SG 11201706861Q A SG11201706861Q A SG 11201706861QA SG 11201706861Q A SG11201706861Q A SG 11201706861QA SG 11201706861Q A SG11201706861Q A SG 11201706861QA
Authority
SG
Singapore
Prior art keywords
tangles
plaques
humans
animals
compositions
Prior art date
Application number
SG11201706861QA
Other languages
English (en)
Inventor
Judy Cam
Thomas Lake
Qubai Hu
Joel Cummings
Alan D Snow
Original Assignee
Cognitive Clarity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognitive Clarity Inc filed Critical Cognitive Clarity Inc
Publication of SG11201706861QA publication Critical patent/SG11201706861QA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201706861QA 2015-02-27 2016-02-25 Compositions and methods for the treatment of "plaques and tangles" in humans and animals SG11201706861QA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562126026P 2015-02-27 2015-02-27
US201562170822P 2015-06-04 2015-06-04
PCT/US2016/019572 WO2016138270A2 (fr) 2015-02-27 2016-02-25 Compositions et méthodes pour le traitement de "plaques" et de "noeuds" chez les êtres humains et les animaux

Publications (1)

Publication Number Publication Date
SG11201706861QA true SG11201706861QA (en) 2017-09-28

Family

ID=56789214

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201706861QA SG11201706861QA (en) 2015-02-27 2016-02-25 Compositions and methods for the treatment of "plaques and tangles" in humans and animals

Country Status (10)

Country Link
US (3) US10307454B2 (fr)
EP (1) EP3261655B1 (fr)
JP (1) JP6796072B2 (fr)
CN (1) CN107530389B (fr)
AU (1) AU2016222650B2 (fr)
CA (1) CA3015127C (fr)
HK (1) HK1247845A1 (fr)
MX (1) MX381186B (fr)
SG (1) SG11201706861QA (fr)
WO (1) WO2016138270A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201706861QA (en) 2015-02-27 2017-09-28 Cognitive Clarity Inc Compositions and methods for the treatment of "plaques and tangles" in humans and animals
EP3893907A4 (fr) * 2018-12-12 2022-11-30 Cognitive Clarity Inc. Compositions et méthodes pour le traitement de "plaques" et de "noeuds" chez les êtres humains et les animaux
US11883457B1 (en) 2022-09-06 2024-01-30 Optigenex Inc. Method of enhancing cognition in individuals with at least normal cognition

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683698A (en) 1996-08-02 1997-11-04 New England Deaconess Hospital Formulation for alleviating symptoms associated with arthritis
EP1019044B1 (fr) * 1997-05-15 2007-04-11 University of Washington Composition et procedes de traitement de la maladie d'alzheimer et autres amyloidoses
US6264994B1 (en) * 1997-05-15 2001-07-24 University Of Washington Compositions for treating alzheimer's disease and other amyloidoses
US6346280B1 (en) * 1997-05-15 2002-02-12 University Of Washington Composition and methods for inhibiting the formation of brain amyloid deposits
EP1064013A4 (fr) 1998-03-13 2005-05-11 Univ Washington FORMATION $i(IN VITRO) DE PLAQUES AMYLOIDES EN FORME DE CROIX DE MALTE ET AYANT UNE AFFINITE POUR LE ROUGE CONGO, EN VUE DE L'IDENTIFICATION DE COMPOSES THERAPEUTIQUES ANTI-PLAQUE POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER ET DU PRION
JP2003171298A (ja) * 2001-12-11 2003-06-17 Nonogawa Shoji Kk 抗アレルギー剤
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070190075A1 (en) 2003-10-09 2007-08-16 Advangen, Inc. C/O National Institute Of Advance Science And Tech Hair growth stimulant composition
JP4321769B2 (ja) * 2004-04-13 2009-08-26 Towa Corporation 株式会社 抗ヒスタミン用組成物、アレルギ性鼻炎の予防および治療用組成物、花粉症の予防および治療用組成物およびじんま疹治療用組成物
JP4954552B2 (ja) * 2006-01-07 2012-06-20 日本メナード化粧品株式会社 抗アレルギー剤
JP2007230977A (ja) * 2006-03-03 2007-09-13 Naris Cosmetics Co Ltd 顆粒球・マクロファージコロニー刺激因子(gm−csf)産生抑制剤ii
JP2007277163A (ja) * 2006-04-06 2007-10-25 Uha Mikakuto Co Ltd ジペプチジルペプチダーゼiv阻害剤
TW200812637A (en) * 2006-09-15 2008-03-16 jun-er Wang Vegetable composition for cleaning oral cavity
JP2010013423A (ja) * 2008-07-07 2010-01-21 Lion Corp ジペプチジルペプチダーゼ−iv阻害剤
JP5688606B2 (ja) 2012-02-17 2015-03-25 株式会社シェフコ 機能性原料を含有する水素含有飲料の製造方法
SG11201706861QA (en) * 2015-02-27 2017-09-28 Cognitive Clarity Inc Compositions and methods for the treatment of "plaques and tangles" in humans and animals

Also Published As

Publication number Publication date
US20190350996A1 (en) 2019-11-21
WO2016138270A3 (fr) 2016-10-27
US20190240279A9 (en) 2019-08-08
EP3261655A4 (fr) 2018-10-10
AU2016222650A1 (en) 2017-09-07
JP6796072B2 (ja) 2020-12-02
US10350258B2 (en) 2019-07-16
MX381186B (es) 2025-03-12
US11376300B2 (en) 2022-07-05
HK1247845A1 (zh) 2018-10-05
CN107530389B (zh) 2021-10-26
WO2016138270A2 (fr) 2016-09-01
CN107530389A (zh) 2018-01-02
US20170333512A1 (en) 2017-11-23
US20160250273A1 (en) 2016-09-01
CA3015127A1 (fr) 2016-09-01
CA3015127C (fr) 2023-10-10
MX2017010873A (es) 2018-11-12
JP2018513838A (ja) 2018-05-31
US10307454B2 (en) 2019-06-04
EP3261655B1 (fr) 2025-04-09
AU2016222650B2 (en) 2021-11-04
EP3261655A2 (fr) 2018-01-03

Similar Documents

Publication Publication Date Title
IL268406A (en) Preparations and methods for treating hemoglobin diseases
IL298689B1 (en) Preparations and methods for suppressing masp-3 for the treatment of various diseases and conditions
IL260257A (en) Preparations and methods for the treatment of hemoglobinopathies
IL266674A (en) Preparations and methods for treating an opioid overdose
IL290150A (en) Compounds and methods for treating chronic pain
RS65319B1 (sr) 8-cijano-5-piperidino-hinolini kao tlr7/8 antagonisti i njihova upotreba u lečenju imunoloških poremećaja
IL260352B (en) Methods and preparations for the treatment of neurological disease
IL266047A (en) Methods and preparations for the treatment of Fabry disease
IL275182A (en) Preparations and methods for the treatment of metabolic conditions
ZA201706919B (en) Fixed dose combinations and formulations comprising etc1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
IL263477A (en) Compositions and methods for the treatment or prevention of oxalate-related disorders
LT3373922T (lt) Kompozicijos ir būdai skirti naudoti homocistinurijos gydyme
SG11201705524SA (en) Compositions and methods for the treatment of inflammation and pain
ZA201900984B (en) Methods and compositions for the treatment of warts
SG11201706861QA (en) Compositions and methods for the treatment of "plaques and tangles" in humans and animals
GB201621737D0 (en) Compositions and methods of treatment
PL3352742T3 (pl) Kompozycje zawierające triterpenoidy do leczenia choroby alzheimera i choroby parkinsona
IL261779A (en) Preparations for the treatment and prevention of hoof and claw disease
IL259383A (en) A compound for use in the prevention and treatment of neurodegenerative diseases
ZA201706985B (en) Compositions for the treatment of fibrosis and fibrosis-related conditions
IL265911A (en) Epilimod preparations and methods of using them in the treatment of Alzheimer's disease
ZA201801945B (en) Compositions and methods for the treatment of parkinson's disease
IL246608A0 (en) Preparations and methods for treating heart disease
SG11202106222YA (en) Compositions and methods for the treatment of "plaques and tangles" in humans and animals
HK40052550A (en) Compositions and methods for the treatment of "plaques and tangles" in humans and animals